Issue 1, 2021

BODIPY-linked cis-dichlorido zinc(ii) conjugates: the strategic design of organelle-specific next-generation theranostic photosensitizers

Abstract

Dipicolylamine (dpa) based cis-dichlorido zinc(II) complexes [Zn(L1–3)Cl2] (1–3), where L2 and L3 are non-iodo and di-iodo BODIPY-appended dpa in 2 and 3, and L1 is dpa in control complex 1, were prepared and characterized and their photocytotoxicity was studied. Complexes 2 and 3 were developed as potential substitutes for zinc(II)–porphyrins/phthalocyanines that are photodynamic therapeutic agents with moderate activity owing to their inherent hydrophobicity and aggregation-induced deactivation mechanism. In our approach, we strategically designed hybrid inorganic–organic zinc–BODIPY conjugates as theranostic photosensitizers. The structurally characterized diamagnetic Zn(II) cis-dichlorido complexes mimic cisplatin and serve as new-generation photosensitizers with enhanced aqueous solubility and mito-DNA targeting propensity while imparting significant physiological stability to the heavy atom tethered BODIPY ligand, L3. The BODIPY complexes showed a visible band near 500 nm (ε ∼ 34 000–44 000 dm3 mol−1 cm−1) and an emission band at 507 nm for 2 in 1% DMSO-Dulbecco's phosphate buffered saline. The labile chlorido ligands (ΛM ∼ 200 S m2 mol−1 in 9 : 1 H2O–DMSO) generated positively charged complexes inside the cellular medium enabling them to cross the mitochondrial membrane for this organelle-selective localization and singlet oxygen-mediated apoptotic photocytotoxicity at nanomolar concentrations for 3 in HeLa and MCF-7 cells in light (400–700 nm), while being less active in the dark.

Graphical abstract: BODIPY-linked cis-dichlorido zinc(ii) conjugates: the strategic design of organelle-specific next-generation theranostic photosensitizers

Supplementary files

Article information

Article type
Paper
Submitted
25 Sep 2020
Accepted
17 Nov 2020
First published
18 Nov 2020

Dalton Trans., 2021,50, 103-115

BODIPY-linked cis-dichlorido zinc(II) conjugates: the strategic design of organelle-specific next-generation theranostic photosensitizers

A. Bhattacharyya, A. Jameei, R. Saha, A. Garai, A. A. Karande and A. R. Chakravarty, Dalton Trans., 2021, 50, 103 DOI: 10.1039/D0DT03342A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements